Corporate Investor

DongKoo Bio&Pharma

DongKoo Bio&Pharma, established in 1983, is a corporate investor based in Seoul. The firm manufactures pharmaceutical and bio products, prescription medicine, cosmetics, and medical devices, focusing on dermatology and urology.

DongKoo Bio&Pharma

DongKoo Bio&Pharma, established in 1983, is a corporate investor based in Seoul. The firm manufactures pharmaceutical and bio products, prescription medicine, cosmetics, and medical devices, focusing on dermatology and urology. It operates its own CMO business.

General information

Firm type

Corporate Investor

Year founded

1983

AUM

Location

Region

Country

City

Seoul

Corporate office

14th Floor, M’state Building B, 114, Beobwon-ro Songpa-gu

Frequently asked questions

What is DongKoo Bio&Pharma?

DongKoo Bio&Pharma is a corporate investor headquartered in Seoul.

When was DongKoo Bio&Pharma founded?

DongKoo Bio&Pharma was founded in 1983.

Where is DongKoo Bio&Pharma headquartered?

DongKoo Bio&Pharma is headquartered in Seoul.

What does Altss track for DongKoo Bio&Pharma?

Altss maintains an OSINT-verified profile of DongKoo Bio&Pharma covering investment focus (ESG policy, ticket size, target IRR, currency preference, regional focuses, industry focuses, technological focuses), team (service providers and advisors), deals (company deals and fund commitments), assets (real estate, public market positions, private companies, art and cultural holdings, philanthropy and foundations), and network (club memberships, associations, and event participation). Detailed values are available to Altss subscribers.

What is DongKoo Bio&Pharma's website?

DongKoo Bio&Pharma's public website is www.dongkoo.com. Verified contact details for principals and decision-makers are available to Altss subscribers.

What type of firm is DongKoo Bio&Pharma?

DongKoo Bio&Pharma is classified by Altss as a Corporate Investor.

How does Altss source intelligence on DongKoo Bio&Pharma?

Altss combines OSINT (open-source intelligence) with regulatory filings, public disclosures, and licensed data partners. Source provenance is tracked to support compliance-ready research workflows.

How fresh is the Altss profile for DongKoo Bio&Pharma?

DongKoo Bio&Pharma's profile is part of Altss's continuous-refresh dataset, with a full update cycle at least every 30 days and priority changes applied as new information is verified.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classLive OSINT deal alerts
Start your free trial

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo